Theravance Biopharma, a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, announced the appointment of Deepika R. Pakianathan to its Board of Directors. Since 2001, Dr. Pakianathan has served as a Managing Member at Delphi Ventures, a venture capital firm focused on biotechnology and medical device investments and leads…